Skip to content

Avalyn Pharma Inc.

AVLN

CIK 0001540171 · Pharmaceutical Preparations · Nasdaq

  • Genoa Pharmaceuticals, Inc. (until 2017-05-24)
← back to feed
Revenue (TTM)
—
Q1 Jun 2026
Net Income (TTM)
—
Q1 Jun 2026
EPS Diluted (TTM)
—
Q1 Jun 2026
Gross Margin
—
Q1 Jun 2026
Operating Margin
—
Q1 Jun 2026
Net Margin
—
Q1 Jun 2026
Free Cash Flow (TTM)
—
Q1 Jun 2026
Cash
$92.31M
Q1 Jun 2026
Total Debt
$14.81M
Q1 Jun 2026
Shares Outstanding
44.33M sh
Q1 Jun 2026

Recent filings